Spouting Rock Asset Management’s Perficient Inc PRFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.18M Buy
17,966
+978
+6% +$60.2K 0.43% 47
2023
Q3
$983K Sell
16,988
-7,288
-30% -$499K 0.31% 57
2023
Q2
$2.02M Buy
24,276
+3,123
+15% +$230K 0.73% 29
2023
Q1
$1.53M Hold
21,153
0.54% 43
2022
Q4
$1.48M Buy
21,153
+49
+0.2% +$3.38K 1.1% 31
2022
Q3
$1.37M Sell
21,104
-1,286
-6% -$107K 1.05% 34
2022
Q2
$2.05M Buy
22,390
+1,763
+9% +$175K 1.33% 27
2022
Q1
$2.27M Hold
20,627
1.9% 27
2021
Q4
$2.67M Sell
20,627
-13,167
-39% -$1.73M 2.09% 21
2021
Q3
$3.91M Sell
33,794
-20,029
-37% -$2.06M 1.95% 9
2021
Q2
$4.33M Sell
53,823
-5,923
-10% -$417K 1.33% 9
2021
Q1
$3.81M Sell
59,746
-12,685
-18% -$718K 1.18% 16
2020
Q4
$3.45M Buy
+72,431
New +$3.29M 1.09% 14

Other funds holding PRFT

Spouting Rock Asset Management's PRFT Position: Q4 2023 in Review

Spouting Rock Asset Management increased its Perficient Inc (PRFT) stake by 5.8% in Q4 2023, buying an estimated $60.2K and bringing the position to 17,966 shares worth $1.18M. The position accounts for 0.43% of the portfolio, ranked #47.

Spouting Rock Asset Management first reported a position in PRFT in Q4 2020 and has held it in 13 quarters since. The position peaked at $4.33M in Q2 2021. 258 funds tracked by Wall St. Rank hold PRFT as of Q4 2023.

  • Spouting Rock Asset Management held 17,966 shares of Perficient Inc worth $1.18M as of Q4 2023.
  • Spouting Rock Asset Management bought 978 Perficient Inc shares in Q4 2023, an estimated $60.2K.
  • Perficient Inc made up 0.43% of Spouting Rock Asset Management's portfolio in Q4 2023, its #47 holding.
  • Spouting Rock Asset Management first reported a position in Perficient Inc in Q4 2020 and has held it in 13 quarters since.
  • Spouting Rock Asset Management's Perficient Inc position peaked at $4.33M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Perficient Inc as of Q4 2023.

Based on Spouting Rock Asset Management's 13F filing for Q4 2023, filed 16 Feb 2024.